Raymond James Financial
PAHC icon

Raymond James Financial’s Phibro Animal Health PAHC Stock Holding History

Raymond James Financial’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04M Sell
65,031
-16,626
-20% -$702K ﹤0.01% 3459
2026
Q1 		$4.52M Buy
81,657
+14,824
+22% +$706K ﹤0.01% 2678
2025
Q4 		$2.5M Sell
66,833
-44,790
-40% -$1.82M ﹤0.01% 3091
2025
Q3 		$4.52M Buy
111,623
+61,473
+123% +$2.03M ﹤0.01% 2528
2025
Q2 		$1.28M Sell
50,150
-2,197
-4% -$47.9K ﹤0.01% 3409
2025
Q1 		$1.12M Sell
52,347
-156
-0.3% -$3.49K ﹤0.01% 3407
2024
Q4 		$1.1M Buy
+52,503
New +$1.21M ﹤0.01% 3386

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Raymond James Financial's PAHC Position: Q2 2026 in Review

Raymond James Financial reduced its Phibro Animal Health (PAHC) stake by 20% in Q2 2026, selling an estimated $702K and leaving 65,031 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #3459.

Raymond James Financial first reported a position in PAHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.52M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Raymond James Financial held 65,031 shares of Phibro Animal Health worth $2.04M as of Q2 2026.
  • Raymond James Financial sold 16,626 Phibro Animal Health shares in Q2 2026, an estimated $702K.
  • Phibro Animal Health made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3459 holding.
  • Raymond James Financial first reported a position in Phibro Animal Health in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Phibro Animal Health position peaked at $4.52M in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.